Capital Flow Monitor · Sponsors · CIK 2115201
DNA SEQ 2, INC.
1255 E VISTA WAY #157, VISTA, CA, 92084 · 585-987-2800
Pharmaceuticals · Corporation· inc. DELAWARE true 2022
Fit score
—
Offering
$1.2M
Sold
$1.2M
% sold
100.0%
Investors
32
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-03-11 | D ·current | 506(b) | $1.2M | $1.2M | 100.0% | 32 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Andrew Nappin — Executive Officer, Vista, CA
- Stuart E. Siegel — Director, Vista, CA
- Janusz Maria Sowadski — Director, Vista, CA
- Eric Ladizinsky — Director, Vista, CA
- Thomas M. Wheeler — Director, Vista, CA
-
Benjamin Anderson — Director, Vista, CA
1 other raise
- Low Rate Co., Inc. $3.3M of $3.3M · 98.6%
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.